Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05286736 · ClinicalTrials.gov registry record
Neuroplasticity in Parkinson's Disease
A clinical trial of Parkinson Disease and Parkinson, sponsored by University of Minnesota.
- Recruiting
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT05286736 is a study of Parkinson Disease and Parkinson that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 50 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05286736, a study of Parkinson Disease and Parkinson, is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this project is to increase our understanding of the early state and temporal evolution of neuroplastic changes in the cortex and subthalamic nucleus (STN) of people with PD, and the relationship of these changes to the emergence and expression of PD motor and non-motor signs. Neurophysiological biomarkers derived from this work may be important for the early detection and prediction of progression of disease. They can also provide the means to assess the efficacy of interventions designed to prevent or slow disease progression.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Neuroimaging
- DIAGNOSTIC_TEST Quantitative assessments
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2021-03-01 |
| Est. Completion | 2028-11-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05286736
The ClinicalTrials.gov registry entry for NCT05286736 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Parkinson Disease appearing as the primary indexed condition, and to 2 interventions - of which Neuroimaging is the first listed.
NCT05286736 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT05286736 about?
NCT05286736 is a clinical study titled "Neuroplasticity in Parkinson's Disease". The purpose of this project is to increase our understanding of the early state and temporal evolution of neuroplastic changes in the cortex and subthalamic nucleus (STN) of people with PD, and the relationship of these changes to the emergence and expression of PD motor and non-motor signs. Neuroph...
What is the current status of trial NCT05286736?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2021-03-01. Estimated completion is 2028-11-09.
What conditions does trial NCT05286736 study?
This clinical trial studies the following conditions: Parkinson Disease, Parkinson.
What interventions are being tested in trial NCT05286736?
The interventions under investigation include: Neuroimaging (DIAGNOSTIC_TEST), Quantitative assessments (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05286736?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05286736 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease
RECRUITING · NA
-
Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis
RECRUITING
-
University of Delaware Parkinson's Disease Registry
RECRUITING
-
Neocortical Microarchitecture of Executive Function
RECRUITING · NA
-
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
RECRUITING · NA
-
Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.